Global Rhinitis Medicine Supply, Demand and Key Producers, 2023-2029

May 2023 | 107 pages | ID: GE34C3CA29B3EN
GlobalInfoResearch

Abstracts

The global Rhinitis Medicine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Rhinitis Medicine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Rhinitis Medicine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Rhinitis Medicine that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Rhinitis Medicine total production and demand, 2018-2029, (K Units)

Global Rhinitis Medicine total production value, 2018-2029, (USD Million)

Global Rhinitis Medicine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Rhinitis Medicine consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Rhinitis Medicine domestic production, consumption, key domestic manufacturers and share

Global Rhinitis Medicine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Rhinitis Medicine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Rhinitis Medicine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)

This reports profiles key players in the global Rhinitis Medicine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline, Regeneron Pharmaceuticals, Neurent Medical, Lotus, Glenmark, Taiho Pharmaceutical, Hikma Pharmaceuticals, Med Globe Therapeutics Limited and Stallergenes Greer, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Rhinitis Medicine market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Rhinitis Medicine Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Rhinitis Medicine Market, Segmentation by Type

• Antihistamines
• Nasal Spray Steroids
• Antileukotrienes

Global Rhinitis Medicine Market, Segmentation by Application

• Allergic Rhinitis
• Infectious Rhinitis
• Others

Companies Profiled:

• GlaxoSmithKline
• Regeneron Pharmaceuticals
• Neurent Medical
• Lotus
• Glenmark
• Taiho Pharmaceutical
• Hikma Pharmaceuticals
• Med Globe Therapeutics Limited
• Stallergenes Greer
• AstraZeneca
• Bayer Global

Key Questions Answered

1. How big is the global Rhinitis Medicine market?

2. What is the demand of the global Rhinitis Medicine market?

3. What is the year over year growth of the global Rhinitis Medicine market?

4. What is the production and production value of the global Rhinitis Medicine market?

5. Who are the key producers in the global Rhinitis Medicine market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Rhinitis Medicine Introduction
1.2 World Rhinitis Medicine Supply & Forecast
  1.2.1 World Rhinitis Medicine Production Value (2018 & 2022 & 2029)
  1.2.2 World Rhinitis Medicine Production (2018-2029)
  1.2.3 World Rhinitis Medicine Pricing Trends (2018-2029)
1.3 World Rhinitis Medicine Production by Region (Based on Production Site)
  1.3.1 World Rhinitis Medicine Production Value by Region (2018-2029)
  1.3.2 World Rhinitis Medicine Production by Region (2018-2029)
  1.3.3 World Rhinitis Medicine Average Price by Region (2018-2029)
  1.3.4 North America Rhinitis Medicine Production (2018-2029)
  1.3.5 Europe Rhinitis Medicine Production (2018-2029)
  1.3.6 China Rhinitis Medicine Production (2018-2029)
  1.3.7 Japan Rhinitis Medicine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Rhinitis Medicine Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Rhinitis Medicine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Rhinitis Medicine Demand (2018-2029)
2.2 World Rhinitis Medicine Consumption by Region
  2.2.1 World Rhinitis Medicine Consumption by Region (2018-2023)
  2.2.2 World Rhinitis Medicine Consumption Forecast by Region (2024-2029)
2.3 United States Rhinitis Medicine Consumption (2018-2029)
2.4 China Rhinitis Medicine Consumption (2018-2029)
2.5 Europe Rhinitis Medicine Consumption (2018-2029)
2.6 Japan Rhinitis Medicine Consumption (2018-2029)
2.7 South Korea Rhinitis Medicine Consumption (2018-2029)
2.8 ASEAN Rhinitis Medicine Consumption (2018-2029)
2.9 India Rhinitis Medicine Consumption (2018-2029)

3 WORLD RHINITIS MEDICINE MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World Rhinitis Medicine Production Value by Manufacturer (2018-2023)
3.2 World Rhinitis Medicine Production by Manufacturer (2018-2023)
3.3 World Rhinitis Medicine Average Price by Manufacturer (2018-2023)
3.4 Rhinitis Medicine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global Rhinitis Medicine Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for Rhinitis Medicine in 2022
  3.5.3 Global Concentration Ratios (CR8) for Rhinitis Medicine in 2022
3.6 Rhinitis Medicine Market: Overall Company Footprint Analysis
  3.6.1 Rhinitis Medicine Market: Region Footprint
  3.6.2 Rhinitis Medicine Market: Company Product Type Footprint
  3.6.3 Rhinitis Medicine Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: Rhinitis Medicine Production Value Comparison
  4.1.1 United States VS China: Rhinitis Medicine Production Value Comparison (2018 & 2022 & 2029)
  4.1.2 United States VS China: Rhinitis Medicine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Rhinitis Medicine Production Comparison
  4.2.1 United States VS China: Rhinitis Medicine Production Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Rhinitis Medicine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Rhinitis Medicine Consumption Comparison
  4.3.1 United States VS China: Rhinitis Medicine Consumption Comparison (2018 & 2022 & 2029)
  4.3.2 United States VS China: Rhinitis Medicine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Rhinitis Medicine Manufacturers and Market Share, 2018-2023
  4.4.1 United States Based Rhinitis Medicine Manufacturers, Headquarters and Production Site (States, Country)
  4.4.2 United States Based Manufacturers Rhinitis Medicine Production Value (2018-2023)
  4.4.3 United States Based Manufacturers Rhinitis Medicine Production (2018-2023)
4.5 China Based Rhinitis Medicine Manufacturers and Market Share
  4.5.1 China Based Rhinitis Medicine Manufacturers, Headquarters and Production Site (Province, Country)
  4.5.2 China Based Manufacturers Rhinitis Medicine Production Value (2018-2023)
  4.5.3 China Based Manufacturers Rhinitis Medicine Production (2018-2023)
4.6 Rest of World Based Rhinitis Medicine Manufacturers and Market Share, 2018-2023
  4.6.1 Rest of World Based Rhinitis Medicine Manufacturers, Headquarters and Production Site (State, Country)
  4.6.2 Rest of World Based Manufacturers Rhinitis Medicine Production Value (2018-2023)
  4.6.3 Rest of World Based Manufacturers Rhinitis Medicine Production (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Rhinitis Medicine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Antihistamines
  5.2.2 Nasal Spray Steroids
  5.2.3 Antileukotrienes
5.3 Market Segment by Type
  5.3.1 World Rhinitis Medicine Production by Type (2018-2029)
  5.3.2 World Rhinitis Medicine Production Value by Type (2018-2029)
  5.3.3 World Rhinitis Medicine Average Price by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Rhinitis Medicine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Allergic Rhinitis
  6.2.2 Infectious Rhinitis
  6.2.3 Others
6.3 Market Segment by Application
  6.3.1 World Rhinitis Medicine Production by Application (2018-2029)
  6.3.2 World Rhinitis Medicine Production Value by Application (2018-2029)
  6.3.3 World Rhinitis Medicine Average Price by Application (2018-2029)

7 COMPANY PROFILES

7.1 GlaxoSmithKline
  7.1.1 GlaxoSmithKline Details
  7.1.2 GlaxoSmithKline Major Business
  7.1.3 GlaxoSmithKline Rhinitis Medicine Product and Services
  7.1.4 GlaxoSmithKline Rhinitis Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.1.5 GlaxoSmithKline Recent Developments/Updates
  7.1.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.2 Regeneron Pharmaceuticals
  7.2.1 Regeneron Pharmaceuticals Details
  7.2.2 Regeneron Pharmaceuticals Major Business
  7.2.3 Regeneron Pharmaceuticals Rhinitis Medicine Product and Services
  7.2.4 Regeneron Pharmaceuticals Rhinitis Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.2.5 Regeneron Pharmaceuticals Recent Developments/Updates
  7.2.6 Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
7.3 Neurent Medical
  7.3.1 Neurent Medical Details
  7.3.2 Neurent Medical Major Business
  7.3.3 Neurent Medical Rhinitis Medicine Product and Services
  7.3.4 Neurent Medical Rhinitis Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.3.5 Neurent Medical Recent Developments/Updates
  7.3.6 Neurent Medical Competitive Strengths & Weaknesses
7.4 Lotus
  7.4.1 Lotus Details
  7.4.2 Lotus Major Business
  7.4.3 Lotus Rhinitis Medicine Product and Services
  7.4.4 Lotus Rhinitis Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.4.5 Lotus Recent Developments/Updates
  7.4.6 Lotus Competitive Strengths & Weaknesses
7.5 Glenmark
  7.5.1 Glenmark Details
  7.5.2 Glenmark Major Business
  7.5.3 Glenmark Rhinitis Medicine Product and Services
  7.5.4 Glenmark Rhinitis Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.5.5 Glenmark Recent Developments/Updates
  7.5.6 Glenmark Competitive Strengths & Weaknesses
7.6 Taiho Pharmaceutical
  7.6.1 Taiho Pharmaceutical Details
  7.6.2 Taiho Pharmaceutical Major Business
  7.6.3 Taiho Pharmaceutical Rhinitis Medicine Product and Services
  7.6.4 Taiho Pharmaceutical Rhinitis Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.6.5 Taiho Pharmaceutical Recent Developments/Updates
  7.6.6 Taiho Pharmaceutical Competitive Strengths & Weaknesses
7.7 Hikma Pharmaceuticals
  7.7.1 Hikma Pharmaceuticals Details
  7.7.2 Hikma Pharmaceuticals Major Business
  7.7.3 Hikma Pharmaceuticals Rhinitis Medicine Product and Services
  7.7.4 Hikma Pharmaceuticals Rhinitis Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.7.5 Hikma Pharmaceuticals Recent Developments/Updates
  7.7.6 Hikma Pharmaceuticals Competitive Strengths & Weaknesses
7.8 Med Globe Therapeutics Limited
  7.8.1 Med Globe Therapeutics Limited Details
  7.8.2 Med Globe Therapeutics Limited Major Business
  7.8.3 Med Globe Therapeutics Limited Rhinitis Medicine Product and Services
  7.8.4 Med Globe Therapeutics Limited Rhinitis Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.8.5 Med Globe Therapeutics Limited Recent Developments/Updates
  7.8.6 Med Globe Therapeutics Limited Competitive Strengths & Weaknesses
7.9 Stallergenes Greer
  7.9.1 Stallergenes Greer Details
  7.9.2 Stallergenes Greer Major Business
  7.9.3 Stallergenes Greer Rhinitis Medicine Product and Services
  7.9.4 Stallergenes Greer Rhinitis Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.9.5 Stallergenes Greer Recent Developments/Updates
  7.9.6 Stallergenes Greer Competitive Strengths & Weaknesses
7.10 AstraZeneca
  7.10.1 AstraZeneca Details
  7.10.2 AstraZeneca Major Business
  7.10.3 AstraZeneca Rhinitis Medicine Product and Services
  7.10.4 AstraZeneca Rhinitis Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.10.5 AstraZeneca Recent Developments/Updates
  7.10.6 AstraZeneca Competitive Strengths & Weaknesses
7.11 Bayer Global
  7.11.1 Bayer Global Details
  7.11.2 Bayer Global Major Business
  7.11.3 Bayer Global Rhinitis Medicine Product and Services
  7.11.4 Bayer Global Rhinitis Medicine Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.11.5 Bayer Global Recent Developments/Updates
  7.11.6 Bayer Global Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Rhinitis Medicine Industry Chain
8.2 Rhinitis Medicine Upstream Analysis
  8.2.1 Rhinitis Medicine Core Raw Materials
  8.2.2 Main Manufacturers of Rhinitis Medicine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Rhinitis Medicine Production Mode
8.6 Rhinitis Medicine Procurement Model
8.7 Rhinitis Medicine Industry Sales Model and Sales Channels
  8.7.1 Rhinitis Medicine Sales Model
  8.7.2 Rhinitis Medicine Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Rhinitis Medicine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Rhinitis Medicine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Rhinitis Medicine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Rhinitis Medicine Production Value Market Share by Region (2018-2023)
Table 5. World Rhinitis Medicine Production Value Market Share by Region (2024-2029)
Table 6. World Rhinitis Medicine Production by Region (2018-2023) & (K Units)
Table 7. World Rhinitis Medicine Production by Region (2024-2029) & (K Units)
Table 8. World Rhinitis Medicine Production Market Share by Region (2018-2023)
Table 9. World Rhinitis Medicine Production Market Share by Region (2024-2029)
Table 10. World Rhinitis Medicine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Rhinitis Medicine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Rhinitis Medicine Major Market Trends
Table 13. World Rhinitis Medicine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Rhinitis Medicine Consumption by Region (2018-2023) & (K Units)
Table 15. World Rhinitis Medicine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Rhinitis Medicine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Rhinitis Medicine Producers in 2022
Table 18. World Rhinitis Medicine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Rhinitis Medicine Producers in 2022
Table 20. World Rhinitis Medicine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Rhinitis Medicine Company Evaluation Quadrant
Table 22. World Rhinitis Medicine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Rhinitis Medicine Production Site of Key Manufacturer
Table 24. Rhinitis Medicine Market: Company Product Type Footprint
Table 25. Rhinitis Medicine Market: Company Product Application Footprint
Table 26. Rhinitis Medicine Competitive Factors
Table 27. Rhinitis Medicine New Entrant and Capacity Expansion Plans
Table 28. Rhinitis Medicine Mergers & Acquisitions Activity
Table 29. United States VS China Rhinitis Medicine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Rhinitis Medicine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Rhinitis Medicine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Rhinitis Medicine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Rhinitis Medicine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Rhinitis Medicine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Rhinitis Medicine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Rhinitis Medicine Production Market Share (2018-2023)
Table 37. China Based Rhinitis Medicine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Rhinitis Medicine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Rhinitis Medicine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Rhinitis Medicine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Rhinitis Medicine Production Market Share (2018-2023)
Table 42. Rest of World Based Rhinitis Medicine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Rhinitis Medicine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Rhinitis Medicine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Rhinitis Medicine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Rhinitis Medicine Production Market Share (2018-2023)
Table 47. World Rhinitis Medicine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Rhinitis Medicine Production by Type (2018-2023) & (K Units)
Table 49. World Rhinitis Medicine Production by Type (2024-2029) & (K Units)
Table 50. World Rhinitis Medicine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Rhinitis Medicine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Rhinitis Medicine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Rhinitis Medicine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Rhinitis Medicine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Rhinitis Medicine Production by Application (2018-2023) & (K Units)
Table 56. World Rhinitis Medicine Production by Application (2024-2029) & (K Units)
Table 57. World Rhinitis Medicine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Rhinitis Medicine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Rhinitis Medicine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Rhinitis Medicine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 62. GlaxoSmithKline Major Business
Table 63. GlaxoSmithKline Rhinitis Medicine Product and Services
Table 64. GlaxoSmithKline Rhinitis Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. GlaxoSmithKline Recent Developments/Updates
Table 66. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 67. Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. Regeneron Pharmaceuticals Major Business
Table 69. Regeneron Pharmaceuticals Rhinitis Medicine Product and Services
Table 70. Regeneron Pharmaceuticals Rhinitis Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Regeneron Pharmaceuticals Recent Developments/Updates
Table 72. Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
Table 73. Neurent Medical Basic Information, Manufacturing Base and Competitors
Table 74. Neurent Medical Major Business
Table 75. Neurent Medical Rhinitis Medicine Product and Services
Table 76. Neurent Medical Rhinitis Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Neurent Medical Recent Developments/Updates
Table 78. Neurent Medical Competitive Strengths & Weaknesses
Table 79. Lotus Basic Information, Manufacturing Base and Competitors
Table 80. Lotus Major Business
Table 81. Lotus Rhinitis Medicine Product and Services
Table 82. Lotus Rhinitis Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Lotus Recent Developments/Updates
Table 84. Lotus Competitive Strengths & Weaknesses
Table 85. Glenmark Basic Information, Manufacturing Base and Competitors
Table 86. Glenmark Major Business
Table 87. Glenmark Rhinitis Medicine Product and Services
Table 88. Glenmark Rhinitis Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Glenmark Recent Developments/Updates
Table 90. Glenmark Competitive Strengths & Weaknesses
Table 91. Taiho Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. Taiho Pharmaceutical Major Business
Table 93. Taiho Pharmaceutical Rhinitis Medicine Product and Services
Table 94. Taiho Pharmaceutical Rhinitis Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Taiho Pharmaceutical Recent Developments/Updates
Table 96. Taiho Pharmaceutical Competitive Strengths & Weaknesses
Table 97. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 98. Hikma Pharmaceuticals Major Business
Table 99. Hikma Pharmaceuticals Rhinitis Medicine Product and Services
Table 100. Hikma Pharmaceuticals Rhinitis Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Hikma Pharmaceuticals Recent Developments/Updates
Table 102. Hikma Pharmaceuticals Competitive Strengths & Weaknesses
Table 103. Med Globe Therapeutics Limited Basic Information, Manufacturing Base and Competitors
Table 104. Med Globe Therapeutics Limited Major Business
Table 105. Med Globe Therapeutics Limited Rhinitis Medicine Product and Services
Table 106. Med Globe Therapeutics Limited Rhinitis Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Med Globe Therapeutics Limited Recent Developments/Updates
Table 108. Med Globe Therapeutics Limited Competitive Strengths & Weaknesses
Table 109. Stallergenes Greer Basic Information, Manufacturing Base and Competitors
Table 110. Stallergenes Greer Major Business
Table 111. Stallergenes Greer Rhinitis Medicine Product and Services
Table 112. Stallergenes Greer Rhinitis Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Stallergenes Greer Recent Developments/Updates
Table 114. Stallergenes Greer Competitive Strengths & Weaknesses
Table 115. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 116. AstraZeneca Major Business
Table 117. AstraZeneca Rhinitis Medicine Product and Services
Table 118. AstraZeneca Rhinitis Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. AstraZeneca Recent Developments/Updates
Table 120. Bayer Global Basic Information, Manufacturing Base and Competitors
Table 121. Bayer Global Major Business
Table 122. Bayer Global Rhinitis Medicine Product and Services
Table 123. Bayer Global Rhinitis Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Global Key Players of Rhinitis Medicine Upstream (Raw Materials)
Table 125. Rhinitis Medicine Typical Customers
Table 126. Rhinitis Medicine Typical Distributors

List Of Figures

LIST OF FIGURES

Figure 1. Rhinitis Medicine Picture
Figure 2. World Rhinitis Medicine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Rhinitis Medicine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Rhinitis Medicine Production (2018-2029) & (K Units)
Figure 5. World Rhinitis Medicine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Rhinitis Medicine Production Value Market Share by Region (2018-2029)
Figure 7. World Rhinitis Medicine Production Market Share by Region (2018-2029)
Figure 8. North America Rhinitis Medicine Production (2018-2029) & (K Units)
Figure 9. Europe Rhinitis Medicine Production (2018-2029) & (K Units)
Figure 10. China Rhinitis Medicine Production (2018-2029) & (K Units)
Figure 11. Japan Rhinitis Medicine Production (2018-2029) & (K Units)
Figure 12. Rhinitis Medicine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Rhinitis Medicine Consumption (2018-2029) & (K Units)
Figure 15. World Rhinitis Medicine Consumption Market Share by Region (2018-2029)
Figure 16. United States Rhinitis Medicine Consumption (2018-2029) & (K Units)
Figure 17. China Rhinitis Medicine Consumption (2018-2029) & (K Units)
Figure 18. Europe Rhinitis Medicine Consumption (2018-2029) & (K Units)
Figure 19. Japan Rhinitis Medicine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Rhinitis Medicine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Rhinitis Medicine Consumption (2018-2029) & (K Units)
Figure 22. India Rhinitis Medicine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Rhinitis Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Rhinitis Medicine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Rhinitis Medicine Markets in 2022
Figure 26. United States VS China: Rhinitis Medicine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Rhinitis Medicine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Rhinitis Medicine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Rhinitis Medicine Production Market Share 2022
Figure 30. China Based Manufacturers Rhinitis Medicine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Rhinitis Medicine Production Market Share 2022
Figure 32. World Rhinitis Medicine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Rhinitis Medicine Production Value Market Share by Type in 2022
Figure 34. Antihistamines
Figure 35. Nasal Spray Steroids
Figure 36. Antileukotrienes
Figure 37. World Rhinitis Medicine Production Market Share by Type (2018-2029)
Figure 38. World Rhinitis Medicine Production Value Market Share by Type (2018-2029)
Figure 39. World Rhinitis Medicine Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Rhinitis Medicine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Rhinitis Medicine Production Value Market Share by Application in 2022
Figure 42. Allergic Rhinitis
Figure 43. Infectious Rhinitis
Figure 44. Others
Figure 45. World Rhinitis Medicine Production Market Share by Application (2018-2029)
Figure 46. World Rhinitis Medicine Production Value Market Share by Application (2018-2029)
Figure 47. World Rhinitis Medicine Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Rhinitis Medicine Industry Chain
Figure 49. Rhinitis Medicine Procurement Model
Figure 50. Rhinitis Medicine Sales Model
Figure 51. Rhinitis Medicine Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source